Email Us Here

New Study Shows Severe Hypophosphatemia Diagnosed in More Than Half of Users of Iron Injection Drug, Injectafer

The remarkable findings add further criticism to Injectafer's own labeling which fails to even mention severe or persistent hypophosphatemia, let alone adequately warn of the increased rates.